nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy
|
Wiersinga, Wilmar M |
|
2017 |
5 |
2 |
p. 134-142 9 p. |
artikel |
2 |
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial
|
Thabit, Hood |
|
2017 |
5 |
2 |
p. 117-124 8 p. |
artikel |
3 |
Closer to closing the loop on inpatient glycaemia
|
Rayman, Gerry |
|
2017 |
5 |
2 |
p. 81-83 3 p. |
artikel |
4 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 943–56
|
|
|
2017 |
5 |
2 |
p. e1- 1 p. |
artikel |
5 |
Correction to Lancet Diabetes Endocrinol 2017: 5: 125–33
|
|
|
2017 |
5 |
2 |
p. e1- 1 p. |
artikel |
6 |
De-evolution of diagnostic testing for adrenal insufficiency
|
Kline, Gregory A |
|
2017 |
5 |
2 |
p. 88-90 3 p. |
artikel |
7 |
Diabetic macular oedema
|
Tan, Gavin S |
|
2017 |
5 |
2 |
p. 143-155 13 p. |
artikel |
8 |
Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial
|
Pasquel, Francisco J |
|
2017 |
5 |
2 |
p. 125-133 9 p. |
artikel |
9 |
Foods, nutrients, and health: when will our policies catch up with nutrition science?
|
Mozaffarian, Dariush |
|
2017 |
5 |
2 |
p. 85-88 4 p. |
artikel |
10 |
Giant gouty tophi in the hands
|
Han, Bing |
|
2017 |
5 |
2 |
p. 156- 1 p. |
artikel |
11 |
Growing a billion dollar industry
|
Mitchell, Fiona |
|
2017 |
5 |
2 |
p. 96- 1 p. |
artikel |
12 |
How concerned should we be over the long-term safety of growth hormone therapy?
|
Tritos, Nicholas A |
|
2017 |
5 |
2 |
p. 79-81 3 p. |
artikel |
13 |
Inpatient care and diabetes: putting poor glycaemic control to bed
|
The Lancet Diabetes & Endocrinology, |
|
2017 |
5 |
2 |
p. 77- 1 p. |
artikel |
14 |
Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool
|
Geldsetzer, Pascal |
|
2017 |
5 |
2 |
p. 91-92 2 p. |
artikel |
15 |
Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study
|
van der Steen, Manouk |
|
2017 |
5 |
2 |
p. 106-116 11 p. |
artikel |
16 |
Non-communicable disease funding
|
Allen, Luke |
|
2017 |
5 |
2 |
p. 92- 1 p. |
artikel |
17 |
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
|
Schmidt, Amand F |
|
2017 |
5 |
2 |
p. 97-105 9 p. |
artikel |
18 |
PCSK9 inhibition and diabetes: turning to Mendel for clues
|
Lee, Jooho |
|
2017 |
5 |
2 |
p. 78-79 2 p. |
artikel |
19 |
Prediabetes definitions and clinical outcomes
|
Huang, Yuli |
|
2017 |
5 |
2 |
p. 93- 1 p. |
artikel |
20 |
Prediabetes definitions and clinical outcomes
|
Lima, Luís Maurício T R |
|
2017 |
5 |
2 |
p. 92-93 2 p. |
artikel |
21 |
Prediabetes definitions and clinical outcomes – Authors' reply
|
Selvin, Elizabeth |
|
2017 |
5 |
2 |
p. 94- 1 p. |
artikel |
22 |
Research in brief
|
Kang, Seema |
|
2017 |
5 |
2 |
p. 95- 1 p. |
artikel |
23 |
Sitagliptin plus basal insulin: simplifying in-hospital diabetes treatment?
|
Nauck, Michael A |
|
2017 |
5 |
2 |
p. 83-85 3 p. |
artikel |